Monthly Archives: June 2018
Sponsors struggle with Ministerial discretion
The 2017 Medicines Australia Strategic Agreement with the Australian Government extended the existing five-year anniversary statutory price reduction (SPR) of 5% for F1 medicines and introduced new SPRs for drugs that have been listed for ten years and fifteen years … Continue reading
Posted in Life Sciences Industry, Market Access, PBS
Tagged Medicines Australia, PBS, Research, Sponsors
Comments Off on Sponsors struggle with Ministerial discretion
